Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 65, Issue 6, Pages 879-884Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1365-2125.2008.03126.x
Keywords
cerebrospinal fluid; child; diclofenac; infant; non-steroidal anti-inflammatory agents; pharmacokinetics
Categories
Ask authors/readers for more resources
AIMS The primary aim was to study the cerebrospinal fluid (CSF) penetration of intravenous diclofenac in children. The secondary aim was to evaluate the plasma diclofenac concentration at the onset of wound pain after inguinal surgery in children. METHODS A total of 31 children (24 boys) aged 3 months to 12 years received a single intravenous injection of diclofenac 1 mg kg(-1). Paired CSF and blood samples were obtained 5min to 22 h (median 69 min) later. In children having inguinal surgery a second blood sample was obtained at the time that the children felt wound pain for the first time after surgery. Diclofenac concentrations in CSF, plasma and protein free plasma were measured by gas chromatography with mass spectrometric detection. RESULTS In the 28 CSF samples obtained at 5 min to 3 h 43 min after injection, diclofenac concentrations ranged between 0.5 and 4.7 mu g l(-1). At 5.5 h the CSF concentration was 0.1 mu g l(-1), and no diclofenac was detected in the two CSF samples obtained at 22 h. The median of plasma diclofenac concentration at the time when pain returned after inguinal surgery was 104 mu g l(-1) (range 70-272 mu g l(-1)). No serious or unexpected adverse effects were reported. CONCLUSIONS Diclofenac penetrates the CSF rapidly, and a sufficient concentration to inhibit cyclooxygenase enzymes is sustained for up to 4 h.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available